Overview

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

Status:
Recruiting
Trial end date:
2022-09-08
Target enrollment:
Participant gender:
Summary
To Evaluate the Efficacy and Safety of Combination Therapy of AGT and AGZ Versus Monotherapy of AGT in Patients With Primary Hypercholesterolemia.
Phase:
Phase 3
Details
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd